---

title: Pneumonia Risk Stratification Tools
authors:
    - Michelle Lin, MD
created: 2011/02/25
updates: null
categories:
    - Pulmonology
    - Infectious Disease
    - EBM

---

# Pneumonia: Risk Stratification Scoring Tools

## Pneumonia Severity Index (PSI) 

-   ([Fine et al., JAMA 1997)](http://www.ncbi.nlm.nih.gov/pubmed/?term=8995086)
-   Pneumonia Patient Outcomes Research Team (PORT)
-   A large derivation and validation study with &gt;50,000 patients
-   Best identifies low-risk/ low-mortality patients
-   Tends to miss higher-risk pneumonia in younger patients because score is based on age 
-   Does not factor in immunosuppression (eg. HIV) and poor social support 

| **Risk factors**                    | **Points**     |
|-------------------------------------|:----------------:|
| Men                                 | Age (years)    |
| Women                               | Age (years)-10 |
| Nursing home resident               | +10            |
| History of neoplasm                 | +30            |
| History of liver disease            | +20            |
| History of heart failure            | +10            |
| History of stroke                   | +10            |
| History of renal failure            | +10            |
| Altered mental status               | +20            |
| RR ≥ 30 breaths/ min                | +20            |
| SBP &lt; 90 mmHg                    | +20            |
| Temp &lt; 95F (35C) or ≥104F (40C)  | +15            |
| HR ≥ 125 bpm                        | +10            |
| Arterial pH &lt; 7.35               | +30            |
| BUN &gt; 30 mg/dL                   | +20            |
| Na &lt; 130 mmol/L                  | +20            |
| Glucose ≥250 mg/dL                  | +10            |
| Hematocrit &lt; 30%                 | +10            |
| PaO2 &lt; 60 mmHg                   | +10            |
| Pleural effusion                    | +10            |

| **PSI Class**  | **Total Points** | **30-Day Mortality**  | **Disposition** |
|:---------:|:-----------------:|:-----------:|:----------------:|
| I       | &lt; 51          | 0.1%        | Outpatient      |
| II      | 51-70            | 0.6%        | Outpatient      |
| III     | 71-90            | 0.9%        | Outpatient vs short-stay inpatient        |
| IV      | 91-130           | 9.3%        | Inpatient       |
| V       | &gt; 130         | 27.0%       | Inpatient ICU   |

## CURB-65 Severity Score

Supported by ([British Thoracic Society Standards of Care Committee](http://www.ncbi.nlm.nih.gov/pubmed/?term=11713364) &[ ](http://www.ncbi.nlm.nih.gov/pubmed/?term=15808136)[Aujesky et al, Am J Med, 2005](http://www.ncbi.nlm.nih.gov/pubmed/?term=15808136)) 

-   Best identifies high-risk/ high-mortality patients
-   Tends to misclassify moderate-risk pneumonia patients (as low-risk) 
-   Does not account for co-morbidities and hypoxemia

|        | **Risk Factor**                                   | **Points** |
|:--------:|---------------------------------------------------|:------------:|
| **C**  | **C**onfusion                                     | 1          |
| **U**  | Uremia (BUN &gt;19 mg/dL)                         | 1          |
| **R**  | **R**R ≥ 30 breaths/min                           | 1          |
| **B**  | **B**P low (SBP &lt;90 mmHg or DBP &lt;60 mmHg) | 1          |
| **65** | Age ≥ **65** years                                | 1          |

| **Total Points** | **30-Day Mortality**  | **Disposition**                    |
|:-----------------:|:-------------:|:----------------------------------|
| 0                | 0.6%        | Outpatient                         |
| 1                | 3.2%        | Outpatient                         |
| 2                | 13.0%       | Outpatient or short-stay inpatient |
| 3                | 17%         | Inpatient                          |
| 4                | 41.5%       | Inpatient, likely ICU              |
| 5                | 57.0%       | Inpatient ICU                      |

## SMART-COP

Supported by Australian CAP Study ([Charles et al., Clin Infect Dis, 2008](http://www.ncbi.nlm.nih.gov/pubmed/?term=18558884))

-   Tool to predict need for intensive respiratory or vasopressor support (IRVS) 

<table>
<colgroup>
<col width="33%" />
<col width="33%" />
<col width="33%" />
</colgroup>
<thead>
<tr class="header">
<th><br />
</th>
<th><strong>Risk factor</strong></th>
<th><strong>Points</strong></th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td><strong>S</strong></td>
<td><strong>S</strong>ystolic BP &lt; 90 mmHg</td>
<td>2</td>
</tr>
<tr class="even">
<td><strong>M</strong></td>
<td><strong>M</strong>ultilobar CXR involvement</td>
<td>1</td>
</tr>
<tr class="odd">
<td><strong>A</strong></td>
<td><strong>A</strong>lbumin &lt; 3.5 g/dL</td>
<td>1</td>
</tr>
<tr class="even">
<td><strong>R</strong></td>
<td>If age ≤ 50 years: <strong>R</strong>R ≥ 25 breaths/min <br />
If age &gt; 50 years: <strong>R</strong>R ≥ 30 breaths min <br />
</td>
<td>1</td>
</tr>
<tr class="odd">
<td><strong>T</strong></td>
<td><strong>T</strong>achycardia HR ≥ 125 bpm </td>
<td>1</td>
</tr>
<tr class="even">
<td><strong>C</strong></td>
<td><strong>C</strong>onfusion (new onset)</td>
<td>1<br />
</td>
</tr>
<tr class="odd">
<td><strong>O</strong></td>
<td><strong>O</strong>xygen low<br />

<p>If age ≤50 years: </p>
<ul>
<li>PaO2 &lt; 70 mmHg, or<br />
</li>
<li>O2 sat ≤ 93%, or<br />
</li>
<li>PaO2/FiO2 &lt; 333<br />
</li>
</ul>
<p>If age &gt;50 years:</p>
<ul>
<li>PaO2 &lt; 60 mmHg, or</li>
<li>O2 sat ≤ 90%, or </li>
<li>PaO2/FiO2 &lt; 250 </li>
</ul></td>
<td>2</td>
</tr>
<tr class="even">
<td><strong>P</strong></td>
<td>Arterial <strong>p</strong>H &lt; 7.35</td>
<td>2</td>
</tr>
</tbody>
</table>

| **Total points** | **Risk of needing IRVS** |
|:-----------------:|--------------------------|
| 0-2              | Low                      |
| 3-4              | Moderate (1 in 8)       |
| 5-6              | High (1 in 3)            |
| ≥ 7              | Very high (2 in 3)       |



## References

-   [Aujesky D et. al. Prospective comparison of three validated prediction rules for prognosis in community-acquired pneumonia. Am J Med. 2005 Apr;118(4):384-92.](http://www.ncbi.nlm.nih.gov/pubmed/?term=15808136)
-   [Fine MJ et. al. A prediction rule to identify low-risk patients with community-acquired pneumonia.N Engl J Med. 1997 Jan 23;336(4):243-50.](http://www.ncbi.nlm.nih.gov/pubmed/?term=8995086)
-   [Charles PG et. al. SMART-COP: a tool for predicting the need for intensive respiratory or vasopressor support in community-acquired pneumonia. Clin Infect Dis. 2008 Aug 1;47(3):375-84.](http://www.ncbi.nlm.nih.gov/pubmed/?term=18558884)
-   [British Thoracic Society Standards of Care Committee. BTS Guidelines for the Management of Community Acquired Pneumonia in Adults. Thorax. 2001 Dec;56 Suppl 4:IV1-64.](http://www.ncbi.nlm.nih.gov/pubmed/?term=11713364)
